125552-89-8

Basic information

• Product Name: 4-BROMOMETHYLTETRAHYDROPYRAN
• Synonyms: 4-(BROMOMETHYL)-TETRAHYDRO-2H-PYRAN;4-BROMOMETHYLTETRAHYDROPYRAN;4-(Bromomethyl)tetrahydropyrane;4-(Bromomethyl)tetrahydropyran ,97%;4-(Bromomethyl)tetrahydro-2H-pyran 97%;4-bromomethytetrahydropyran;Tetrahydro-2H-pyran-4-yl-MethylbroMide;4-(BroMoMethyl)tetrahydro...
• CAS NO: 125552-89-8
• Molecular Formula: C₆H₁₁BrO
• Molecular Weight: 179.05
• Product Categories: blocks;Bromides;Heterocycles;Halides;Heterocyclic Compounds
• Mol File: 125552-89-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 88 °C
• Flash Point: 80.8 °C
• Appearance: /
• Density: 1.359 g/cm³
• Vapor Pressure: 0.359mmHg at 25°C
• Refractive Index: 1.475
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 4-BROMOMETHYLTETRAHYDROPYRAN(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMOMETHYLTETRAHYDROPYRAN(125552-89-8)
• EPA Substance Registry System: 4-BROMOMETHYLTETRAHYDROPYRAN(125552-89-8)

Safety Data

• Hazard Codes: C,Xn
• Statements: 36/37/38-34-22
• Safety Statements: 26-36/37/39-45-23
• RIDADR: 3265
• HazardClass: 8
• PackingGroup: Ⅲ
• Hazardous Substances Data: 125552-89-8(Hazardous Substances Data)

Usage

Chemical Properties

Viscous liquid

InChI:InChI=1/C6H11BrO/c7-5-6-1-3-8-4-2-6/h6H,1-5H2

Upstream product

• 14774-37-9 (tetrahydro-2H-pyran-4-yl)methanol 
• 132291-95-3 4-(methanesulfonyloxymethyl)tetrahydropyran 
• 558-13-4 carbon tetrabromide 
• 110238-91-0 tetrahydropyran-4-carboxylic acid methyl ester 
• 5337-03-1 tetrahydro-2H-pyran-4-carboxylic acid 
• 101691-65-0 toluene-4-sulfonic acid tetrahydropyran-4-ylmethyl ester 

Downstream Products

• 850429-50-4 2-(tetrahydro-2H-pyran-4-yl)acetonitrile 
• 174485-18-8 [3-(Cyclopropyl-{4-hydroxy-2-oxo-6-[1-(tetrahydro-pyran-4-ylmethyl)-propyl]-2H-pyran-3-yl}-methyl)-phenyl]-carbamic acid benzyl ester 
• 1021169-67-4 4-((4-bromophenylsulfonyl)methyl)tetrahydro-2H-pyran 
• 1021169-24-3 (R)-2-methyl-1-{2-[4'-(tetrahydro-pyran-4-ylmethanesulfonyl)-biphenyl-4-yl]-ethyl}-pyrrolidine 
• 1021169-66-3 4-((4-bromophenylthio)methyl)tetrahydro-2H-pyran 
• 1035490-93-7 4-(azidomethyl)tetrahydropyrane 

Relevant articles and documents

NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9

The present invention relates to an inhibitor of cyclin-dependent kinase CDK9, having a structure of formula (I). The present invention also provides a method of treating a cancer of a precancerous condition related to CDK9 activity with the inhibitor and a use of the same.

Pharmaceutical compositions and methods for effecting dopamine release

Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2]octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.1]octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.

Twisted Si=N bonds: Matrix isolation of bridgehead silanimines

We report the IR and UV-vis spectra of three bridgehead silanimines, 1-sila-2-azabicyclo[3.2.2]non-1(2)-ene, 1-sila-2-azabicyclo[3.2.1]oct-1(2)-ene, and 1-sila-2-azabicyclo[2.2.2]oct-1(2)-ene, prepared in matrix isolation by UV irradiation of bridgehead s